|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.490 CNY | 0.00% |
|
-1.79% | -25.51% |
| 06-02 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.64B 833M 732M 683M 627M 1.17B 79.79B 1.2B 8.1B 3.17B 39.48B 3.13B 3.06B 136B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.5B 664M 584M 545M 500M 936M 63.64B 959M 6.46B 2.53B 31.49B 2.49B 2.44B 109B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.66% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 week | -1.79% | ||
| Current month | -7.42% | ||
| 1 month | +8.28% | ||
| 3 months | -19.62% | ||
| 6 months | -29.34% | ||
| Current year | -25.51% |
| 1 week | 5.22 |  | 5.7 |
| 1 month | 5.2 | | 7.33 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 24/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 11/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.79% | -31.72% | -44.38% | 833M | |
| -0.87% | +4.07% | +58.63% | +166.26% | 1,089B | |
| -0.15% | +3.93% | +58.04% | +58.59% | 643B | |
| +0.71% | +4.06% | +37.84% | +76.21% | 465B | |
| -1.69% | +8.36% | +38.80% | +34.26% | 359B | |
| -0.51% | +3.35% | +39.00% | +43.76% | 303B | |
| +1.50% | +3.40% | +17.71% | +17.41% | 267B | |
| +0.79% | +4.32% | -25.07% | -36.02% | 226B | |
| -3.42% | +5.69% | +27.44% | +65.22% | 212B | |
| -1.71% | +1.87% | +16.24% | +74.39% | 167B | |
| Average | -0.30% | +4.39% | +23.69% | +45.57% | 373.2B | |
| Weighted average by Cap. | -0.38% | +5.14% | +40.75% | +81.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.54M 85.71M 80M 73.42M 137M 9.34B 141M 949M 371M 4.62B 366M 358M 15.98B | 624M 92.11M 80.93M 75.54M 69.33M 130M 8.82B 133M 896M 350M 4.37B 346M 338M 15.09B |
| Net income | -74.07M -10.94M -9.61M -8.97M -8.23M -15.41M -1.05B -15.79M -106M -41.61M -518M -41.07M -40.18M -1.79B | -347M -51.28M -45.06M -42.06M -38.6M -72.25M -4.91B -74.03M -499M -195M -2.43B -193M -188M -8.4B |
| Net Debt | -1.98B -293M -257M -240M -220M -413M -28.04B -423M -2.85B -1.11B -13.88B -1.1B -1.08B -47.97B | -1.14B -169M -148M -138M -127M -238M -16.15B -243M -1.64B -641M -7.99B -633M -619M -27.62B |
Employees
901
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | CN¥5.490 | 0.00% | 30,713,900 |
| 28/07/26 | CN¥5.490 | -1.44% | 32,161,652 |
| 27/07/26 | CN¥5.570 | +5.29% | 40,087,736 |
| 24/07/26 | CN¥5.290 | -5.37% | 29,723,100 |
| 23/07/26 | CN¥5.590 | +0.72% | 34,374,338 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
